Kadmon Holdings, Inc. (KDMN): Price and Financial Metrics
KDMN Stock Summary
- Kadmon Holdings Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 11.46% of US listed stocks.
- KDMN's price/sales ratio is 75.87; that's higher than the P/S ratio of 95.67% of US stocks.
- As for revenue growth, note that KDMN's revenue has grown 62.67% over the past 12 months; that beats the revenue growth of 91.97% of US companies in our set.
- Stocks that are quantitatively similar to KDMN, based on their financial statements, market capitalization, and price volatility, are ONCT, FPRX, CLSN, SILC, and OMER.
- Visit KDMN's SEC page to see the company's official filings. To visit the company's web site, go to www.kadmon.com.
KDMN Stock Price Chart Interactive Chart >
KDMN Price/Volume Stats
|Current price||$3.66||52-week high||$5.73|
|Prev. close||$3.85||52-week low||$3.14|
|Day high||$3.87||Avg. volume||3,782,457|
|50-day MA||$4.52||Dividend yield||N/A|
|200-day MA||$4.25||Market Cap||628.85M|
Kadmon Holdings, Inc. (KDMN) Company Bio
Kadmon Holdings, LLC discovers, develops, and commercializes small molecules and biologics to address unmet medical needs. The company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; co-promotes a product for chronic weight management; distributes products for chorea, cytomegalovirus retinitis, and for the prevention of CMV disease. The company is based in New York City, New York
KDMN Latest News Stream
|Loading, please wait...|
KDMN Latest Social Stream
View Full KDMN Social Stream
Latest KDMN News From Around the Web
Below are the latest news stories about Kadmon Holdings Inc that investors may wish to consider to help them evaluate KDMN as an investment opportunity.
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Kadmon Holdings, Inc. Investors to Secure Counsel Before Important Deadline - KDMN
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and March 10, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 2, 2021.
SHAREHOLDER ALERT: REGI LDOS KDMN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / April 8, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Kadmon Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - April 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kadmon Holdings, Inc. ("Kadmon" or "the Company") (NASDAQ: KDMN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between October 1, 2020 and March 10, 2021, ...
KDMN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kadmon Holdings, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Kadmon securities between October 1, 2020 and March 10, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/kdmn. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kadmon Holdings, Inc., of Class Action Lawsuit and Upcoming Deadline - KDMN
NEW YORK, NY / ACCESSWIRE / April 8, 2021 / Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ:KDMN) and certain of its officers.
KDMN Price Returns
Continue Researching KDMNHere are a few links from around the web to help you further your research on Kadmon Holdings Inc's stock as an investment opportunity:
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!